Blom, D., Speijer, D., Linthorst, G. E., Donker-Koopman, W. G., Strijland, A., & Aerts, J. M. F. G. (2003). Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A mRNA. The American Society of Human Genetics.
Citación estilo ChicagoBlom, Daniël, Dave Speijer, Gabor E. Linthorst, Wilma G. Donker-Koopman, Anneke Strijland, y Johannes M. F. G. Aerts. Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A MRNA. The American Society of Human Genetics, 2003.
Cita MLABlom, Daniël, et al. Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A MRNA. The American Society of Human Genetics, 2003.
Precaución: Estas citas no son 100% exactas.